Connor, Clark & Lunn Investment Management (CC&L)
RLAY icon

Connor, Clark & Lunn Investment Management (CC&L)’s Relay Therapeutics RLAY Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.33M Buy
837,038
+447,475
+115% +$4M 0.02% 527
2025
Q4 		$3.3M Buy
+389,563
New +$2.78M 0.01% 785
2024
Q2 		– Sell
-43,382
Closed -$360K – 1645
2024
Q1 		$360K Sell
43,382
-22,954
-35% -$224K ﹤0.01% 1205
2023
Q4 		$730K Buy
66,336
+27,134
+69% +$229K ﹤0.01% 952
2023
Q3 		$330K Buy
+39,202
New +$422K ﹤0.01% 1120

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return